Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer
Clinical trial NCT05345860 · RECRUITING
Trial details
- NCT number
- NCT05345860
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-24
- Primary completion
- 2024-03-24
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.